Prescription for Change: Policy Recommendations for Women’s Health Research

Zurich, Switzerland | 22 May, 2025 | BY: WEF Global Women’s Alliance for Health

Women are half the population yet health issues that affect them exclusively, differently or disproportionately remain under-researched and under-funded. For example, just 7% of healthcare research targets conditions that exclusively affect women.

We need more representative research to fuel better diagnosis and treatment. Closing this research gap is not only a moral imperative, it’s critical to unlocking smarter science, stronger economies and fairer futures.

To achieve this aim, the World Economic Forum’s Global Alliance for Women’s Health has published a new white paper presenting 5 actionable policy recommendations to help close the research gap negatively impacting the health of women everywhere.

The white paper has been produced in partnership with Kearney, Gates Foundation and a working group of more than 45 organizations including the Women’s Brain Foundation.

The Global Alliance for Women’s Health is calling on policy-makers and healthcare leaders to recognize that improving research around the health of women is essential to broader medical progress.

Read the full article.

Return Home

Make a Donation

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.